| Literature DB >> 35158732 |
Jurgen Germann1, Gelareh Zadeh1,2,3,4,5, Alireza Mansouri6, Walter Kucharczyk7, Andres M Lozano1,5,8, Alexandre Boutet7.
Abstract
Neuro-oncology research is broad and includes several branches, one of which is neuroimaging. Magnetic resonance imaging (MRI) is instrumental for the diagnosis and treatment monitoring of patients with brain tumors. Most commonly, structural and perfusion MRI sequences are acquired to characterize tumors and understand their behaviors. Thanks to technological advances, structural brain MRI can now be transformed into a so-called average brain accounting for individual morphological differences, which enables retrospective group analysis. These normative analyses are uncommonly used in neuro-oncology research. Once the data have been normalized, voxel-wise analyses and spatial mapping can be performed. Additionally, investigations of underlying connectomics can be performed using functional and structural templates. Additionally, a recently available template of spatial transcriptomics has enabled the assessment of associated gene expression. The few published normative analyses have shown relationships between tumor characteristics and spatial localization, as well as insights into the circuitry associated with epileptogenic tumors and depression after cingulate tumor resection. The wide breadth of possibilities with normative analyses remain largely unexplored, specifically in terms of connectomics and imaging transcriptomics. We provide a framework for performing normative analyses in oncology while also highlighting their limitations. Normative analyses are an opportunity to address neuro-oncology questions from a different perspective.Entities:
Keywords: MRI; connectomics; imaging transcriptomics; neuro-oncology; neuroimaging; normative analysis
Year: 2022 PMID: 35158732 PMCID: PMC8833690 DOI: 10.3390/cancers14030464
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.639
Figure 1Normative voxel-based, connectomics, and imaging transcriptomics analyses. Examples of outcome maps depicting voxel-based analysis (top), functional connectomic analysis (middle), and structural connectomic analysis (bottom) are shown on the left side of the figure. The resulting spatial maps of those analyses can then be used as input for the spatial transcriptomics analysis outlined on the right side of the figure. Atlas segmentation is used to calculate the correlation of spatial gene expression and imaging results across all brain areas. The thresholded subset of the list identifies the significantly implicated genes. This list can then be further investigated using, for example, gene ontology analysis.
Figure 2Framework for normative brain analyses. Following typical research project prerequisites (upper left side of the image), the analysis begins with the native patient MRI. The feature of interest (e.g., tumor) is manually segmented (red arrow) using the native patient image. The native patient brain is then normalized (transformed) to MNI space and the estimated transforms applied to the native patient brain (for quality control) and the segmented feature (green arrows). The segmented feature (e.g., tumor) in MNI space is the main input for further processing, such as voxel-based group analysis (yellow arrow), and is used as seeds in normative structural (turquoise arrow) and functional (purple arrow) connectome analyses to derive brain-wide connectivity patterns. dMRI = diffusion-weighted MRI; MNI = Montreal Neurological Institute; MRI = Magnetic resonance imaging; rsfMRI = resting state functional MRI.
Figure 3Neuro-oncology applications of normative analyses. Voxel-based, connectomics, and imaging transcriptomics are various tools that can be used when performing normative analyses. Their applications to neuro-oncology are broad and include the assessment of tumor characteristics and behaviors, leading to potential pre- and post-operative improvements for patients.